Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Elevance Health Inc (NYSE: ELV) closed the day trading at $542.34 down -0.13% from the previous closing price of $543.04. In other words, the price has decreased by -$0.13 from its previous closing price. On the day, 0.55 million shares were traded. ELV stock price reached its highest trading level at $545.47 during the session, while it also had its lowest trading level at $541.3.
Ratios:
For a better understanding of ELV, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.58.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, BofA Securities on July 18, 2024, Downgraded its rating to Neutral and sets its target price to $530 from $646 previously.
On June 24, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $643.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $649.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $649 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 05 ’24 when PERU RAMIRO G sold 753 shares for $531.52 per share. The transaction valued at 400,235 led to the insider holds 8,744 shares of the business.
RAMIRO G PERU bought 753 shares of ELV for $400,235 on Aug 05 ’24. On Jul 22 ’24, another insider, BOUDREAUX GAIL, who serves as the President and CEO of the company, sold 34,000 shares for $500.98 each. As a result, the insider received 17,033,395 and left with 126,709 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ELV now has a Market Capitalization of 125761060864 and an Enterprise Value of 117561982976. As of this moment, Elevance’s Price-to-Earnings (P/E) ratio for their current fiscal year is 19.01, and their Forward P/E ratio for the next fiscal year is 13.02. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.58. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73 while its Price-to-Book (P/B) ratio in mrq is 2.98. Its current Enterprise Value per Revenue stands at 0.685 whereas that against EBITDA is 10.332.
Stock Price History:
Over the past 52 weeks, ELV has reached a high of $555.35, while it has fallen to a 52-week low of $431.38. The 50-Day Moving Average of the stock is 2.26%, while the 200-Day Moving Average is calculated to be 6.96%.
Shares Statistics:
Over the past 3-months, ELV traded about 1.07M shares per day on average, while over the past 10 days, ELV traded about 685170 shares per day. A total of 233.07M shares are outstanding, with a floating share count of 230.62M. Insiders hold about 0.55% of the company’s shares, while institutions hold 94.66% stake in the company. Shares short for ELV as of 1722384000 were 1999697 with a Short Ratio of 1.87, compared to 1719532800 on 2191078. Therefore, it implies a Short% of Shares Outstanding of 1999697 and a Short% of Float of 0.86.
Dividends & Splits
ELV’s forward annual dividend rate is 6.22, up from 6.22 a year ago. Against a Trailing Annual Dividend Yield of 0.011454036The stock’s 5-year Average Dividend Yield is 1.14.
Earnings Estimates
The company has 18.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is $6.79, with high estimates of $7.34 and low estimates of $6.05.
Analysts are recommending an EPS of between $37.33 and $37.2 for the fiscal current year, implying an average EPS of $37.26. EPS for the following year is $41.67, with 21.0 analysts recommending between $42.3 and $41.04.
Revenue Estimates
14 analysts predict $43.3B in revenue for the current quarter. It ranges from a high estimate of $44.57B to a low estimate of $41.14B. As of the current estimate, Elevance Health Inc’s year-ago sales were $42.62BFor the next quarter, 14 analysts are estimating revenue of $43.75B. There is a high estimate of $45.37B for the next quarter, whereas the lowest estimate is $41.33B.
A total of 16 analysts have provided revenue estimates for ELV’s current fiscal year. The highest revenue estimate was $175.49B, while the lowest revenue estimate was $167.97B, resulting in an average revenue estimate of $172.6B. In the same quarter a year ago, actual revenue was $170.21BBased on 17 analysts’ estimates, the company’s revenue will be $184.14B in the next fiscal year. The high estimate is $190.56B and the low estimate is $178.28B.
